Replimune Competitors and Similar CompaniesClear all

Nektar Therapeutics's competitors and similar companies include GlycoMimetics, Immunome and AnaptysBio.

	Nektar Therapeutics Nektar Therapeutics is a stage-clinical biopharmaceutical company.	GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.	Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system.	AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
Founding Date	Founding Date 1990	Founding Date 2003	Founding Date 2008	Founding Date 2005
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations San Francisco, US HQ Hyderabad, IN Huntsville, US	Locations Rockville, US HQ	Locations Exton, US HQ	Locations San Diego, US HQ San Diego, US
Employees	Employees 61821% increase	Employees 5025% increase	Employees 264% decrease	Employees 898% decrease
Valuation ($)	Valuation ($) 233.8 m	Valuation ($) 31.6 m	Valuation ($) 746.5 m	Valuation ($) 930.2 m
Financial
Revenue (est.)	Revenue (est.) $55.2m (FY, 2025)	Revenue (est.) $10.8m (FY, 2025)	Revenue (est.) $6.9m (FY, 2025)	Revenue (est.) $234.6m (FY, 2025)
Net income	Net income ($164.1m) (FY, 2025)	Net income ($153.9m) (FY, 2025)	Net income ($212.4m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 45m	Total funding raised $ 101.8m	Total funding raised $ 23.8m	Total funding raised $ 83.9m